Results 1 to 10 of about 13,250 (212)

Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists

BMC Health Services Research, 2022
Background Oral albuterol has worse efficacy and side effects compared with inhaled albuterol, and thus its use has been discouraged for decades. Drug inclusion or exclusion on formularies have been associated with reductions in low-value care.
Anna Volerman, Alison Pelczar, Rena Conti, Christina Ciaccio, Kao-Ping Chua   +4 more
doaj   +2 more sources

Efficacy and safety of as-needed albuterol–budesonide versus albuterol in patients with asthma aged 12 to [PDF]

BMJ Open Respiratory Research
Introduction Asthma among adolescents (aged 12–<18 years) is a common condition with high disease burden. Many are undertreated, at risk of adverse outcomes and exhibit poor adherence to maintenance medication.
Raulin Surujbally, Leonard Benjamin Bacharier, Hengameh Raissy, Samuel Bardsley, Lynn Dunsire, Erik Hermansson, Olami Sobande, Kevin R Murphy   +7 more
doaj   +2 more sources

Limiting Albuterol Use by EMS at the Start of the COVID-19 Pandemic: A Retrospective Analysis of Rapid Deimplementation [PDF]

Western Journal of Emergency Medicine
Introduction: Deimplementation is the process through which an existing practice, procedure, or protocol is discontinued. Past deimplementation efforts in emergency medical services (EMS), such as reduction of liberal oxygen administration, backboard use,
Renoj Varughese, Susan J. Burnett, Hilary Kirk, Ian Wallis, Nan Nan, Chang-Xing Ma, David Hostler, Brian M. Clemency   +7 more
doaj   +2 more sources

Nebulized-Swallowed Albuterol for the Treatment of Food Impaction in Pediatric Patients with Eosinophilic Esophagitis: A Novel Nonendoscopic Approach [PDF]

Journal of Pediatrics: Clinical Practice
Food impaction (FI) is a manifestation of eosinophilic esophagitis (EoE) and requires endoscopic removal. We report the response to nebulized albuterol in 5 children with EoE and FI.
Thirumazhisai S. Gunasekaran, MD, Kiranmai Gorla, MD, James Berman, MD, Vrinda Bhardwaj, MD   +3 more
doaj   +2 more sources

Assessing the cardiovascular and potassium lowering effects of levalbuterol compared to albuterol: a randomized control trial [PDF]

Frontiers in Cardiovascular Medicine
BackgroundBeta-agonists like Levalbuterol and Albuterol are used in the treatment of Hyperkalemia. However, few studies in the medical literature have directly compared the cardiac effects and potassium-lowering efficacy of levalbuterol and albuterol ...
Baraa Shebli, Mike Ghabally, Muhammad Besher Shabouk, Ahmad Yamen Arnaout, Mohamed Besher Zeina, Mahmoud Malhis   +5 more
doaj   +2 more sources

A 10-year interval of cardiovascular effects of albuterol in asthma management: Graphical review [PDF]

Current Research in Pharmacology and Drug Discovery
Asthma is a widespread chronic respiratory disease that requires effective management to reduce exacerbations and improve patient outcomes. Albuterol (salbutamol), a short-acting beta-2-agonist (SABA), remains a mainstay treatment for acute symptom ...
Ghulam H. Abbas, Faaizah Ahmed, Reda Iqbal, Fathimathul Henna, Edmon R. Khouri, Frank W.J.M. Smeenk, Sjaak Pouwels   +6 more
doaj   +2 more sources

Long-acting β2 agonist (LABA) with a long-acting muscarinic receptor antagonist (LAMA) promotes human airway smooth muscle (HASM) relaxation and circumvents β2 adrenergic receptor tachyphylaxis [PDF]

Respiratory Research
To fill the gap in the knowledge between clinical studies and pre-clinical mechanistic studies using combined LABA/LAMA therapy, we hypothesized that the combination is more effective in attenuating excitation-contraction (E-C) coupling compared to ...
Joseph Jude, Nikhil Karmacharya, Rinzhin T. Sherpa, Thomas G. O’Riordan, Cynthia J. Koziol-White, Reynold A. Jr. Panettieri   +5 more
doaj   +2 more sources

Dexmedetomidine as an adjunctive treatment for acute asthma [PDF]

Clinical and Experimental Emergency Medicine, 2021
Objective This study aimed to compare the efficacy of using dexmedetomidine with salbutamol and salbutamol nebulization alone in patients with acute exacerbation of asthma presenting to the emergency department.
Hassan Motamed, Arash Forouzan, Meisam Moezzi, Hossein Alizadeh   +3 more
doaj   +1 more source

Albuterol, Acidosis, and Aneurysms [PDF]

Federal Practitioner, 2021
A patient with a complicated medical history on admission for dyspnea was administered nebulizer therapy but after 72 hours developed asymptomatic acute kidney injury and anion-gap metabolic acidosis.
Lucy, Ma, Christopher, Russo, Raj, Singaraju   +2 more
openaire   +2 more sources

β2-Agonists inhibit TNF-α-induced ICAM-1 expression in human airway parasympathetic neurons. [PDF]

PLoS ONE, 2012
Major basic protein released from eosinophils to airway parasympathetic nerves blocks inhibitory M(2) muscarinic receptors on the parasympathetic nerves, increasing acetylcholine release and potentiating reflex bronchoconstriction.
Zhenying Nie, Allison D Fryer, David B Jacoby   +2 more
doaj   +1 more source